LO8 : Daclatasvir, sofosbuvir, and ribavirin combination...

LO8 : Daclatasvir, sofosbuvir, and ribavirin combination for HCV patients with advanced cirrhosis or posttransplant recurrence: Phase 3 ALLY-1 study

Poordad, F., Schiff, E.R., Vierling, J.M., Landis, C., Fontana, R.J., Yang, R., McPhee, F., Hughes, E., Noviello, S., Swenson, E.S.
How much do you like this book?
What’s the quality of the file?
Download the book for quality assessment
What’s the quality of the downloaded files?
Volume:
62
Language:
english
Journal:
Journal of Hepatology
DOI:
10.1016/S0168-8278(15)30154-9
Date:
April, 2015
File:
PDF, 123 KB
english, 2015
Conversion to is in progress
Conversion to is failed